GBUK Group, a portfolio company of A&M Capital Europe (“AMCE”), a London-based private equity firm with €650 million of commitments under management, has acquired GS Medical Limited, an Irish-based provider of single-use, own-brand and third-party medical devices across the endoscopy, infection, wound care and surgery categories.
Headquartered in Dublin and founded in 2004, GS Medical has built a well-respected brand in Ireland, developing market-leading shares in its core categories. In 2021, the company launched a UK division, which has grown rapidly via sales of its wound care portfolio to both the National Health Service (“NHS”) and the UK private market.
The acquisition of GS Medical represents GBUK’s third acquisition since AMCE’s investment in December 2023. The acquisition continues the key strategic objective of strengthening GBUK’s product presence into new therapeutic areas.
About GBUK Group
Headquartered in the United Kingdom, GBUK Group designs develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK NHS and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK Group has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinged on wrap-around services. To find out more, visit www.gbukgroup.com.
About A&M Capital Europe
AMCE is a London-headquartered private equity investment firm specialising in building pan-European platform companies through buy-and-build and organic growth initiatives. AMCE Fund I currently has €650 million of commitments under management, and Severn represents AMCE’s twenty-third transaction across its eight portfolio companies. More broadly, AMCE is part of A&M Capital, a multi-strategy private equity investment firm that manages commitments totalling ~€5.5 billion across all its investment strategies. In addition, A&M Capital maintains a strategic association with Alvarez & Marsal, one of the world’s largest growth and operationally focused advisory firms. For additional information, please visit A&M Capital Europe’s website at www.a-mcapital.com.